Haemonetics Corporation announced that it received 510(k) clearance from the U.S. FDA on the next-generation software for the Cell Saver® Elite®+ Autotransfusion System, with full market release available now. This software upgrade, named Intelligent Control, offers customers key enhancements to help simplify operations, supporting enhanced efficiency and an improved user experience.
The Cell Saver Elite+ Autotransfusion System is state-of-the-art technology that gives hospitals the ability to recover a patient’s own blood in surgical procedures with the potential for medium to high blood loss, helping to avoid unnecessary allogeneic transfusions while reducing related costs. The new Intelligent Control software provides more than 50 automation enhancements to augment the user experience, including complete user control with a “Manual Mode” option, expanded wash volumes adjustable to the Association for the Advancement of Blood & Biotherapies (AABB) recommended levels, and enhanced Emergency Options.
The Intelligent Control software enhances SmartSuction® and Latham bowl technologies to help maximise the recovery of red blood cells. The new software for the Cell Saver Elite+, helps customers with more versatility and simplicity to best meet their autotransfusion needs.
